[go: up one dir, main page]

AU2017902346A0 - Methods of treating ocular disorders - Google Patents

Methods of treating ocular disorders

Info

Publication number
AU2017902346A0
AU2017902346A0 AU2017902346A AU2017902346A AU2017902346A0 AU 2017902346 A0 AU2017902346 A0 AU 2017902346A0 AU 2017902346 A AU2017902346 A AU 2017902346A AU 2017902346 A AU2017902346 A AU 2017902346A AU 2017902346 A0 AU2017902346 A0 AU 2017902346A0
Authority
AU
Australia
Prior art keywords
methods
ocular disorders
treating ocular
treating
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017902346A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beta Therapeutics Pty Ltd
Original Assignee
Beta Therapeutics Pty Ltd
Filing date
Publication date
Application filed by Beta Therapeutics Pty Ltd filed Critical Beta Therapeutics Pty Ltd
Publication of AU2017902346A0 publication Critical patent/AU2017902346A0/en
Priority to PCT/AU2017/051382 priority Critical patent/WO2018107226A1/en
Priority to EP17880512.3A priority patent/EP3554505A4/en
Priority to AU2017376818A priority patent/AU2017376818A1/en
Priority to RU2019121873A priority patent/RU2019121873A/en
Priority to BR112019012045-9A priority patent/BR112019012045A2/en
Priority to AU2017377659A priority patent/AU2017377659A1/en
Priority to CA3046997A priority patent/CA3046997A1/en
Priority to JP2019552313A priority patent/JP2020503377A/en
Priority to PCT/AU2017/000271 priority patent/WO2018107201A1/en
Priority to PCT/AU2017/000270 priority patent/WO2018107200A1/en
Priority to EP17880657.6A priority patent/EP3555071A4/en
Priority to AU2017376817A priority patent/AU2017376817B2/en
Priority to CN201780086184.XA priority patent/CN110291073A/en
Priority to KR1020197019995A priority patent/KR20190093214A/en
Priority to US16/468,419 priority patent/US11718609B2/en
Priority to EP17881268.1A priority patent/EP3555051A4/en
Priority to US16/475,671 priority patent/US20200093852A1/en
Priority to MX2019006863A priority patent/MX2019006863A/en
Priority to IL267238A priority patent/IL267238A/en
Priority to IL267243A priority patent/IL267243A/en
Priority to IL267229A priority patent/IL267229A/en
Priority to AU2022201731A priority patent/AU2022201731B2/en
Abandoned legal-status Critical Current

Links

AU2017902346A 2016-12-13 2017-06-20 Methods of treating ocular disorders Abandoned AU2017902346A0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
MX2019006863A MX2019006863A (en) 2016-12-13 2017-12-13 Heparanase inhibitors and use thereof.
AU2017376817A AU2017376817B2 (en) 2016-12-13 2017-12-13 Heparanase inhibitors and use thereof
EP17880657.6A EP3555071A4 (en) 2016-12-13 2017-12-13 Heparanase inhibitors and use thereof
AU2017376818A AU2017376818A1 (en) 2016-12-13 2017-12-13 Heparanase inhibitors and use thereof
RU2019121873A RU2019121873A (en) 2016-12-13 2017-12-13 HEPARANASE INHIBITORS AND THEIR APPLICATION
BR112019012045-9A BR112019012045A2 (en) 2016-12-13 2017-12-13 heparanase inhibitors and their use
AU2017377659A AU2017377659A1 (en) 2016-12-13 2017-12-13 Methods of treating ocular disorders
CA3046997A CA3046997A1 (en) 2016-12-13 2017-12-13 Heparanase inhibitors and use thereof
CN201780086184.XA CN110291073A (en) 2016-12-13 2017-12-13 Heparanase inhibitors and application thereof
EP17880512.3A EP3554505A4 (en) 2016-12-13 2017-12-13 Methods of treating ocular disorders
PCT/AU2017/000270 WO2018107200A1 (en) 2016-12-13 2017-12-13 Heparanase inhibitors and use thereof
PCT/AU2017/051382 WO2018107226A1 (en) 2016-12-13 2017-12-13 Methods of treating ocular disorders
PCT/AU2017/000271 WO2018107201A1 (en) 2016-12-13 2017-12-13 Heparanase inhibitors and use thereof
JP2019552313A JP2020503377A (en) 2016-12-13 2017-12-13 Heparanase inhibitors and uses thereof
KR1020197019995A KR20190093214A (en) 2016-12-13 2017-12-13 Heparanase inhibitors and uses thereof
US16/468,419 US11718609B2 (en) 2016-12-13 2017-12-13 Heparanase inhibitors and use thereof
EP17881268.1A EP3555051A4 (en) 2016-12-13 2017-12-13 Heparanase inhibitors and use thereof
US16/475,671 US20200093852A1 (en) 2016-12-13 2017-12-13 Methods of Treating Ocular Disorders
IL267229A IL267229A (en) 2016-12-13 2019-06-11 Methods of treating ocular disorders
IL267238A IL267238A (en) 2016-12-13 2019-06-11 Heparanase inhibitors and use thereof
IL267243A IL267243A (en) 2016-12-13 2019-06-11 Heparanase inhibitors and use thereof
AU2022201731A AU2022201731B2 (en) 2016-12-13 2022-03-11 Heparanase inhibitors and use thereof

Publications (1)

Publication Number Publication Date
AU2017902346A0 true AU2017902346A0 (en) 2017-07-06

Family

ID=

Similar Documents

Publication Publication Date Title
EP3694500A4 (en) Treatment of inflammatory disorders
EP3157463A4 (en) Methods and devices for treating posterior ocular disorders
EP3554505A4 (en) Methods of treating ocular disorders
EP3596063A4 (en) Pyrimidinyl-pyridyloxy-naphthyl compounds and methods of treating ire1-related diseases and disorders
EP3240612A4 (en) Methods of treating retinal diseases
EP3503906A4 (en) Methods for treatment of bile acid-related disorders
EP3651747A4 (en) Compositions and methods for the treatment of eye disorders
EP3429584A4 (en) Compositions and methods for the treatment of presbyopia
IL290069A (en) Methods of treating ocular conditions
EP3630065A4 (en) Treatment of depressive disorders
EP3856169A4 (en) Methods of treating myeloproliferative disorders
EP3310353A4 (en) Compositions and methods for treating and diagnosing ocular disorders
EP3209295A4 (en) Methods of treating ocular conditions
EP3600378A4 (en) Pantids for treatment of autoimmune disorders
EP3658218A4 (en) Treatment of eye disorders
EP3856189A4 (en) Methods of treating myeloproliferative disorders
EP3507277B8 (en) Hydroxynorketamine derivatives for the treatment of disorders
AU2017902346A0 (en) Methods of treating ocular disorders
EP3129054A4 (en) Methods and compositions for the treatment of ocular diseases and disorders
HK40121582A (en) Methods and compositions for treatment of epileptic disorders
HK40055553A (en) Methods of treating myeloproliferative disorders
HK40052689A (en) Methods of treating myeloproliferative disorders
HK40004067A (en) Methods of treating ocular conditions
EP3585380A4 (en) Methods of treating seizure disorders
HK40021761A (en) Methods of preventing or treating ophthalmic diseases